Depressive Disorders - Ireland | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$66.36m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.58%, resulting in a market volume of US$71.75m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$222.30 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Ireland is experiencing significant growth and development.

Customer preferences: Customers in Ireland are increasingly seeking effective treatment options for depressive disorders. They are looking for medications and therapies that can alleviate their symptoms and improve their overall well-being. There is a growing demand for personalized treatment plans that take into account individual needs and preferences. Customers also value accessibility and convenience, preferring treatments that can be easily accessed and integrated into their daily lives.

Trends in the market: One of the key trends in the Depressive Disorders market in Ireland is the increasing adoption of digital health solutions. Telemedicine and online therapy platforms are gaining popularity, allowing individuals to receive treatment and support remotely. This trend has been accelerated by the COVID-19 pandemic, which has highlighted the importance of remote healthcare options. Digital health solutions offer convenience, privacy, and flexibility, making them attractive to customers in Ireland.Another trend in the market is the growing focus on holistic approaches to treating depressive disorders. Customers are seeking treatments that address not only the symptoms of depression but also the underlying causes. This includes lifestyle changes, such as exercise and diet modifications, as well as complementary therapies like acupuncture and mindfulness meditation. The integration of these holistic approaches with traditional medical treatments is becoming more common in Ireland.

Local special circumstances: Ireland has a high prevalence of depressive disorders compared to other countries. This may be attributed to various factors, including the stressful nature of modern life, the impact of the COVID-19 pandemic, and the lack of mental health resources in certain areas. The Irish government has recognized the importance of addressing mental health issues and has implemented initiatives to improve access to mental health services. This has created opportunities for market growth and development in the Depressive Disorders sector.

Underlying macroeconomic factors: The Irish economy has been growing steadily in recent years, which has contributed to increased healthcare spending. The government has allocated more resources to mental health services, including funding for research and development in the field of Depressive Disorders. This has attracted pharmaceutical companies and healthcare providers to invest in the Irish market, leading to the introduction of new treatment options and therapies. The favorable economic conditions in Ireland have also allowed individuals to afford the cost of treatment, further driving market growth.In conclusion, the Depressive Disorders market in Ireland is experiencing growth and development due to customer preferences for effective treatment options, the adoption of digital health solutions, the focus on holistic approaches, the high prevalence of depressive disorders, and the favorable macroeconomic factors. These trends and circumstances are shaping the market landscape in Ireland and creating opportunities for both healthcare providers and customers.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.